Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 4, Issue 2, 2010, Pages 183-188

  Sato, Asaka ^a   Naganuma, Makoto ^a   Asakura, Keiko ^b   Nishiwaki, Yuji ^b   Yajima, Tomoharu ^a   Hisamatsu, Tadakazu ^a   Iwao, Yasushi ^a   Takebayashi, Toru ^b   Watanabe, Mamoru ^c   Hibi, Toshifumi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Crohn's disease; Male IBD patients; Pregnancy; Ulcerative colitis

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; BRANCHDACTYLY; CONCEPTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; CROHN DISEASE; DRUG SAFETY; ENTERITIS; FEMALE; HEALTH SURVEY; HUMAN; JAPANESE; LIVE BIRTH; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEWBORN DISEASE; PALATE MALFORMATION; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; ULCERATIVE COLITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ATTITUDE TO HEALTH; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FERTILITY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; JAPAN; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS; SELF REPORT; YOUNG ADULT;

EID: 77952100716     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.10.004     Document Type: Article

References (21)

1. Olsen K.O., Juul S., Berndtsson I., Oresland T., and Laurberg S. Ulcerative colitis: female fecundity before diagnosis, during disease, and after surgery compared with a population sample. Gastroenterology 122 (2002) 15-19
2. Mahadevan U. Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 55 (2006) 1198-1206
3. Fonager K., Sorensen H.T., Olsen J., Dahlerup J.F., and Rasmussen S.N. Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenterol 93 (1998) 2426-2430
4. Komfeld D., Chattingius S., and Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease-a population-based cohort study. Am J Obstet Gynecol 177 (1997) 942-946
5. Norgard B., Fonager K., Sorensen H.T., and Olsen J. Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 95 (2000) 3165-3170
6. Alstead E.M., Ritchie J.K., Lennard-Jones J.E., Farthing M.J., and Clark M.L. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 99 (1990) 443-446
7. Francella A., Dyan A., Bodian C., Rubin P., Chapman M., and Present D.H. The safety of 6- mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 124 (2003) 9-17
8. Moskovitz D.N., Bodian C., Chapman M.L., Marion J.F., Rubin P., Scherl E., et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol 99 (2004) 656-661
9. Levi A.J., Fisher A.M., Hughes L., and Hendry W.F. Male infertility due to sulphasalazine. Lancet 2 (1979) 276-278
10. Oakberg E.F., Crosthwait C.D., and Raymer G.D. Spermatogenic stage sensitivity to 6- mercaptopurine in the mouse. Mutat Res 94 (1982) 165-178
11. Simpson J.L., and Jauniaux E.R.M. Obstetrics. Normal and problem pregnancies. In: Gabbe S.G., Niebyl J.R., and Simpson J.L. (Eds). Pregnancy loss. 5th ed (2007), Churchill Livingstone Elsevier, Philadelphia 628-645 (Chapter 24)
12. Burnell D., Mayberry J., Calcraft B.J., Moris J.F., and Rhodes J. Male fertility in Crohn's disease. Postgrad Med J 62 (1986) 269-272
13. Toovey S., Hudson E., Hendry W.F., and Levi A.J. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut 22 (1981) 445-451
14. Naz R.K. Modalities for treatment of antisperm antibody mediated infertility: novel perspectives. Am J Reprod Immunol 51 (2004) 390-397
15. Targan S.R., Hanauer S.B., van Deventer S.J., Mayer L., Present D.H., Braakman T., et al. A short-term study of chimeric monocional antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 337 (1997) 1029-1035
16. Present D.H., Rutgeerts P., Targan S.R., Hanauer S.B., Mayer L., van Hogezand R.A., et al. IFX for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340 (1999) 1398-1405
17. Sands B.E., Anderson F.H., Bernstein C.N., Chey W.Y., Feagan B.G., Fedorak R.N., et al. IFX maintenance therapy for fistulizing Crohn's disease. N EngI J Med 350 (2004) 876-885
18. Katz J.A., Antoni C., Keenan G.F., Smith D.E., Jacobs S.J., and Lichtenstein G.R. Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 99 (2004) 2385-2392
19. Mahadevan U., Terdiman J.P., Aron J., Jacobsohn S., and Turek P. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis 11 (2005) 395-399
20. Narendranathan M., Sandler R.S., Suchindran C.M., and Savitz D.A. Male infertility in inflammatory bowel disease. J Clin Gastroenterol 11 (1989) 403-406
21. Ludvigsson J.F., and Ludvigsson J. Inflammatory bowel disease in mother or father and neonatal outcome. Acta Paediatr 91 (2002) 145-151